K23 AR081425/AR/NIAMS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2023	1
2024	6

1

McCormick N, Yokose C, Challener GJ, Joshi AD, Tanikella S, Choi HK. McCormick N, et al. JAMA. 2024 Feb 6;331(5):417-424. doi: 10.1001/jama.2023.26640. JAMA. 2024. PMID: 38319333 Free PMC article.

2

Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study.

McCormick N, Yokose C, Wei J, Lu N, Wexler DJ, Aviña-Zubieta JA, De Vera MA, Zhang Y, Choi HK. McCormick N, et al. Ann Intern Med. 2023 Aug;176(8):1067-1080. doi: 10.7326/M23-0724. Epub 2023 Jul 25. Ann Intern Med. 2023. PMID: 37487215

3

Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin.

McCormick N, Yokose C, Lu N, Wexler DJ, Aviña-Zubieta JA, De Vera MA, McCoy RG, Choi HK. McCormick N, et al. JAMA Intern Med. 2024 Jun 1;184(6):650-660. doi: 10.1001/jamainternmed.2024.0376. JAMA Intern Med. 2024. PMID: 38619822

4

The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout.

Yokose C, McCormick N, Abhishek A, Dalbeth N, Pascart T, Lioté F, Gaffo A, FitzGerald J, Terkeltaub R, Sise ME, Januzzi JL, Wexler DJ, Choi HK. Yokose C, et al. Nat Rev Rheumatol. 2024 Apr;20(4):216-231. doi: 10.1038/s41584-024-01092-x. Epub 2024 Mar 12. Nat Rev Rheumatol. 2024. PMID: 38472344 Review.

5

Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis.

Yokose C, Challener G, Jiang B, Zhou B, McCormick N, Tanikella S, Panchot KMQ, Kohler MJ, Yinh J, Zhang Y, Bates DW, Januzzi JL, Sise M, Wexler D, Choi HK. Yokose C, et al. Semin Arthritis Rheum. 2024 Jun;66:152441. doi: 10.1016/j.semarthrit.2024.152441. Epub 2024 Apr 5. Semin Arthritis Rheum. 2024. PMID: 38657403

6

Frequently Encountered Artifacts in the Application of Dual-Energy Computed Tomography to Cardiovascular Imaging for Urate Crystals in Gout: A Matched-Control Study.

Yokose C, Eide SE, Huber FA, Simeone FJ, Ghoshhajra BB, Shojania K, Nicolaou S, Becce F, Choi HK. Yokose C, et al. Arthritis Care Res (Hoboken). 2024 Jul;76(7):953-963. doi: 10.1002/acr.25312. Epub 2024 Mar 18. Arthritis Care Res (Hoboken). 2024. PMID: 38317327

7

Unclosing Premature Mortality Gap Among Patients With Gout in the US General Population, Independent of Serum Urate and Atherosclerotic Cardiovascular Risk Factors.

McCormick N, Lin K, Yokose C, Lu N, Zhang Y, Choi HK. McCormick N, et al. Arthritis Care Res (Hoboken). 2024 May;76(5):691-702. doi: 10.1002/acr.25292. Epub 2024 Feb 14. Arthritis Care Res (Hoboken). 2024. PMID: 38191784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year